Who is sponsoring NCT04641390?

NCT04641390 is sponsored by Instituto Bernabeu.

What drugs are being tested in NCT04641390?

Interventions in NCT04641390: Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment, Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment.

What condition does NCT04641390 study?

NCT04641390 studies Fertility Disorders.

Is NCT04641390 still recruiting?

NCT04641390 is currently status unknown. Last updated 30 August 2021.

Last reviewed 2021-08-30 · How we verify

NCT04641390

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interaction Between the Vaginal and Seminal Microbiome in Patients With an Altered Vaginal Microbiome Pattern Resistant to Treatment

Status unknown Last updated 30 August 2021

What this trial tests

trial testing Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment in Fertility Disorders in 20 participants. Status unknown.

Timeline

1 February 2021

Primary endpoint
15 December 2021

15 April 2022

Quick facts

Lead sponsor	Instituto Bernabeu
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 February 2021
Primary completion	15 December 2021
Estimated completion	15 April 2022
Sites	1 location across Spain

Drugs / interventions tested

Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment
Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment

Conditions studied

Fertility Disorders — all drugs for Fertility Disorders →

Sponsor

Instituto Bernabeu — full company profile →

Who can join

Adults 18 to 50, male only, with Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It,s a retrospective case-control pilot study is to be carried out. Twenty patients will be included in the study for each branch (a total of 60). The study population will be patients whose partners have a diagnosis of an altered vaginal microbiome with (Cases, n = 20) or without (Controls, n = 20) persistence to drug treatment. Since a normal reference seminal microbiome has not been described, we will include a control group that will consist of sperm donors (n = 20) who are considered fertile potential without reproductive problems. The main objective of the project is to identify the interaction of the vaginal and seminal microbiome patterns in couples in which the vaginal pattern is altered and is persistent to drug treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fertility Disorders

Currently open trials in the same condition.

NCT07017972 — Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model · recruiting
NCT06928337 — Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. · recruiting
NCT06799507 — The Effect of Mindfulness-Based Lifestyle Support Program on Infertile Women · NA · recruiting
NCT04663971 — Fertility and Pregnancy After Surgery IBD Audit · recruiting
NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting

Other Instituto Bernabeu trials

Trials by the same sponsor.

NCT07364526 — Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients · recruiting
NCT07270081 — Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEID · NA · completed
NCT06195163 — TRAP Study: Testosterone for Androgen Receptor Polymorphism · Phase 4 · not yet recruiting
NCT05954962 — Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. · Phase 4 · completed
NCT05815719 — Continuous Double Ovarian Stimulation. · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04641390 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Bernabeu
Last refreshed: 30 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04641390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing